1 results match your criteria: "India. Electronic address: hodpchemistry@velsuniv.ac.in.[Affiliation]"
Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19.
Int J Antimicrob Agents
May 2020
Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Chennai, India. Electronic address:
The Wuhan outbreak of novel Corona virus infection has been the global focus since December 2019. This infection has become a global pandemic. It is highly important to understand the virology of the pathogen and to explore the therapeutic options for management of this pandemic.
View Article and Find Full Text PDF